Release date: 2018-02-23
Recently, the National Health and Family Planning Commission released the latest progress and achievements of major national science and technology projects in the field of medicine and health, of which the latest achievements in infectious diseases are two in vitro diagnostic (IVD) products. The results of these two product developments have been recognized as major innovations and major breakthroughs.
Zhongshan Hospital affiliated to Fudan University has made a major breakthrough in the early diagnosis and treatment of liver cancer, and predicted the recurrence and metastasis technology. The "7 kinds of micro-ribonucleic acid liver cancer detection kits" developed by the company can only diagnose liver cancer by collecting 0.2 ml of plasma. There is no gap in the clinical monitoring of alpha-fetoprotein-negative liver cancer, and the sensitivity and specificity are more than 80%. Another "automatic circulating tumor cell sorting detection system", based on the internationally detected "stem cell-like circulating liver cancer cells in peripheral blood", successfully developed the world's first prototype and test kit. These two world-first technologies with completely independent intellectual property rights have been listed or contracted separately.
The data show that liver cancer is one of the most common malignant tumors in the world. The onset is concealed and there is no specific symptom in the early stage. About 80% of the patients have entered the advanced stage and lost the chance of radical surgery.
Source: China Health Media Group - China Medical News
Flex Clear Tape,Clear Flex Tape,Flex Seal Clear Tape,Clear Flex Seal Tape
Kunshan Jieyudeng Intelligent Technology Co., Ltd. , https://www.jerrytapes.com